|
ISCA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.42980000061854E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.15340001386011E-09 |
| Normal-vs-Stage2 |
6.581800E-04 |
| Normal-vs-Stage3 |
4.661900E-03 |
| Normal-vs-Stage4 |
5.058900E-03 |
| Stage1-vs-Stage2 |
5.966800E-01 |
| Stage1-vs-Stage3 |
1.863750E-01 |
| Stage1-vs-Stage4 |
7.966800E-01 |
| Stage2-vs-Stage3 |
5.446400E-01 |
| Stage2-vs-Stage4 |
9.257200E-01 |
| Stage3-vs-Stage4 |
5.781800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.95490000140819E-08 |
| Normal-vs-AfricanAmerican |
1.13759999975649E-07 |
| Normal-vs-Asian |
5.648600E-01 |
| Caucasian-vs-AfricanAmerican |
6.241000E-01 |
| Caucasian-vs-Asian |
1.329790E-01 |
| AfricanAmerican-vs-Asian |
3.323800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29720000296984E-08 |
| Normal-vs-Female |
3.54589999995714E-06 |
| Male-vs-Female |
2.048200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.350400E-04 |
| Normal-vs-Extreme_Weight |
1.05589999965794E-07 |
| Normal-vs-Obese |
1.02109999999822E-06 |
| Normal-vs-Extreme_Obese |
1.709910E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.656000E-01 |
| Normal_Weight-vs-Obese |
4.922800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.646600E-01 |
| Extreme_Weight-vs-Obese |
8.481600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.513600E-01 |
| Obese-vs-Extreme_Obese |
6.346400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.879800E-03 |
| Normal-vs-Age(41-60Yrs) |
9.97160021221077E-10 |
| Normal-vs-Age(61-80Yrs) |
5.93260000014695E-07 |
| Normal-vs-Age(81-100Yrs) |
1.148270E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.412800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.903000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.488200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.728600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.374400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.927200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.6172401719532E-12 |
| Normal-VS-Type2 PRCC |
1.882340E-03 |
| Normal-VS-KIRP CIMP |
5.278400E-03 |
| Normal-VS-Unclassified PRCC |
2.44480000022307E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.350490E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.394200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.574800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.642000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.052200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.083800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94736999999945E-05 |
| Normal-vs-N1 |
4.137700E-03 |
| Normal-vs-N2 |
3.1906999264919E-10 |
| N0-vs-N1 |
4.794800E-01 |
| N0-vs-N2 |
1.0929000000548E-06 |
| N1-vs-N2 |
1.66685999999361E-05 |
|
|
